U.K. Court Lets Yeda Continue Case Over Erbitux

Law360, New York (October 24, 2007, 12:00 AM EDT) -- A high court in London on Wednesday clarified that inventors on a patent need to prove that they contributed to the invented concept, clearing the way for Yeda Research & Development Co. Ltd. to be named as the inventor of a patent covering the cancer drug Erbitux.

The House of Lords handed down a unanimous decision in the dispute over who invented the subject matter of a key patent covering the use of Israeli pharmaceutical company ImClone Systems Inc.’s Erbitux.

It found that “a person who...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.